EUR 0.45
(-0.22%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -10.92 Million | -6.96 Million | 9.04 Million | -6.22 Million | 2.31 Million | -6.34 Million |
Net Income | -8.1 Million | -5.49 Million | -6.56 Million | 4.61 Million | -3.41 Million | -5.96 Million |
Depreciation & Amortization | 4.42 Million | 4.61 Million | 4.81 Million | 4.74 Million | 3.94 Million | 7.01 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -3.32 Million | -8.32 Million | 9.08 Million | -5.34 Million | 1.84 Million | -251.66 Thousand |
Other non-cash items | 8.26 Million | 2.24 Million | 1.7 Million | -10.23 Million | 5.97 Million | 7.14 Million |
Investing Cash Flow | 1.66 Million | 5.32 Million | -274.13 Thousand | -317.05 Thousand | -6.14 Million | 5.52 Million |
Investments in PPE | -1.14 Million | -1.51 Million | -814.15 Thousand | -766.27 Thousand | -1.91 Million | -1.11 Million |
Acquisitions | -1.57 Million | 6.5 Million | 502.55 Thousand | -499.99 Thousand | -7.4 Million | 135 Thousand |
Investment purchases | - | -6.79 Million | -532.55 Thousand | - | - | - |
Sales/Maturities of investments | 4.47 Million | 290.26 Thousand | 30 Thousand | - | 4.19 Million | 6.5 Million |
Other Investing Activities | -87.27 Thousand | 6.83 Million | 540.01 Thousand | 949.21 Thousand | -1.01 Million | 6.63 Million |
Financing Cash Flow | 8.52 Million | -5.57 Million | 289.85 Thousand | 11.17 Million | 3.39 Million | 447.18 Thousand |
Debt repayment | -2.41 Million | -6.22 Million | -856.64 Thousand | -10.25 Million | -3.04 Million | -447.18 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 7 Million | 556 Thousand | 901.5 Thousand | 2.05 Million | 8 Million | - |
Other Financing Activities | 4.18 Million | 95 Thousand | 245 Thousand | 19.37 Million | -1.55 Million | - |
Accounts receivables | -4.52 Million | -7.5 Million | 7.84 Million | -1.17 Million | -5.39 Million | 3.68 Million |
Accounts payables | 2.17 Million | 695.54 Thousand | 1.55 Million | -4.27 Million | -1.59 Million | -3.53 Million |
Inventory | -984.77 Thousand | -1.5 Million | -308.11 Thousand | 104.58 Thousand | 8.84 Million | -403.13 Thousand |
Other working capital | 2.17 Million | 695.54 Thousand | 1.55 Million | -4.27 Million | -1.59 Million | -3.53 Million |
Cash at beginning of period | 7.45 Million | 14.7 Million | 5.69 Million | 2.34 Million | 1.45 Million | 1.83 Million |
Cash at end of period | 4.16 Million | 7.45 Million | 14.7 Million | 5.64 Million | 2.34 Million | 1.45 Million |
Capital Expenditure | -1.14 Million | -1.51 Million | -814.15 Thousand | -766.27 Thousand | -1.91 Million | -1.11 Million |
Effect of forex changes on cash | - | -38.34 Thousand | -48.62 Thousand | -1.32 Million | 1.31 Million | - |
Net cash flow / Change in cash | -3.28 Million | -7.25 Million | 9 Million | 3.3 Million | 885.63 Thousand | -374.46 Thousand |
Free Cash Flow | -12.06 Million | -8.47 Million | 8.22 Million | -6.98 Million | 405.11 Thousand | -7.45 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.12 Million | -2.12 Million | -8.1 Million | -2.01 Million | -2.01 Million | -4.08 Million |
Depreciation & Amortization | 1.2 Million | 1.2 Million | 4.42 Million | 1.25 Million | 452.33 Thousand | 1.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -824.64 Thousand | -824.64 Thousand | -3.32 Million | -1.2 Million | -1.2 Million | -915.13 Thousand |
Other non-cash items | 31.38 Thousand | 31.38 Thousand | 8.26 Million | -380.6 Thousand | 418.68 Thousand | 1.57 Million |
Investing Cash Flow | 377.69 Thousand | 377.69 Thousand | 1.66 Million | 209.98 Thousand | 209.98 Thousand | 1.24 Million |
Investments in PPE | -322.31 Thousand | -322.31 Thousand | -1.14 Million | -487.94 Thousand | -487.94 Thousand | -166.96 Thousand |
Acquisitions | 250 Thousand | - | -1.57 Million | -1.57 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 1.4 Million | - | 4.47 Million | 2.97 Million | - | 1.5 Million |
Other Investing Activities | 700 Thousand | 700 Thousand | -87.27 Thousand | 697.93 Thousand | 697.93 Thousand | -87.27 Thousand |
Financing Cash Flow | 2.06 Million | 2.06 Million | 8.52 Million | 3.92 Million | 3.92 Million | 673.55 Thousand |
Debt repayment | -3.72 Million | - | -2.41 Million | -1.59 Million | - | -4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.58 Million | - | 7 Million | 7 Million | - | - |
Other Financing Activities | 2.06 Million | 2.06 Million | 4.18 Million | 3.92 Million | 3.92 Million | 4.68 Million |
Accounts receivables | -856.62 Thousand | -856.62 Thousand | -4.52 Million | -1.62 Million | -1.62 Million | -1.26 Million |
Accounts payables | 343.91 Thousand | - | 2.17 Million | 1.9 Million | - | 268.97 Thousand |
Inventory | -139.97 Thousand | -139.97 Thousand | -984.77 Thousand | -531.42 Thousand | -531.42 Thousand | 78.07 Thousand |
Other working capital | 171.95 Thousand | 171.95 Thousand | 2.17 Million | 954.9 Thousand | 954.9 Thousand | 134.48 Thousand |
Cash at beginning of period | 4.16 Million | - | 7.45 Million | 588.23 Thousand | - | 7.45 Million |
Cash at end of period | 5.61 Million | 728.21 Thousand | 4.16 Million | 4.16 Million | 1.78 Million | 588.23 Thousand |
Capital Expenditure | -322.31 Thousand | -322.31 Thousand | -1.14 Million | -487.94 Thousand | -487.94 Thousand | -166.96 Thousand |
Effect of forex changes on cash | - | - | - | - | - | -2.55 Million |
Net cash flow / Change in cash | 1.44 Million | 728.21 Thousand | -3.28 Million | 3.57 Million | 1.78 Million | -6.86 Million |
Free Cash Flow | -2.03 Million | -2.03 Million | -12.06 Million | -2.83 Million | -2.83 Million | -6.39 Million |
OML
OLP
ONC
AVL
300581
SBKO